Results 11 to 20 of about 32,966 (252)

Antipsychotic treatment patterns and cardiometabolic medicine use: current real-world evidence [PDF]

open access: yesEpidemiology and Psychiatric Sciences
Aims Off-label use of antipsychotics, often at low doses, is increasing. Exploring the link between individual antipsychotic treatment patterns, including low-dose continuous use, and cardiometabolic health is crucial to prevent long-term morbidity and ...
Ramya Padmavathy Radha Krishnan   +3 more
doaj   +2 more sources

Determinants of antipsychotic prescription in women detainees admitted to an acute forensic psychiatric unit [PDF]

open access: yesFrontiers in Psychiatry
BackgroundWomen represent a small proportion of the global prison population but carry a disproportionate burden of mental illness. Evidence indicates high rates of psychotropic medication use among women in prison, often independently of the clinical ...
Isabella D’Orta   +7 more
doaj   +2 more sources

Reply: Antipsychotic Agents and Delirium. [PDF]

open access: yesAm J Respir Crit Care Med, 2015
Hsieh SJ   +4 more
europepmc   +4 more sources

Onset of Action of Selected Second-Generation Antipsychotics (Pines)–A Systematic Review and Meta-Analyses

open access: yesBiomedicines, 2022
Recommendations for duration of treatment with antipsychotics before considering a switch vary from 2 to 8 weeks, although several studies suggest a rapid onset of action.
Rikke Meyer   +6 more
doaj   +1 more source

Myocarditis in patients on long-term antipsychotics –mechanism, management and recent updates

open access: yesHeliyon, 2023
Objective: Clozapine is the first atypical antipsychotic drug and was frequently cited as the most effective antipsychotic for treatment-resistant schizophrenia, but it is associated with a concert of significant cardiotoxic side effects.
Patterson Daniel   +6 more
doaj   +1 more source

Loxapine in patient with clozapine-resistant psychosis [PDF]

open access: yesMental Health Clinician, 2021
Clozapine is recognized as the drug of choice for treatment-refractory schizophrenia, but use may be limited because of strict monitoring requirements and adverse effects including severe neutropenia, seizures, and myocarditis.
Jennifer Erley, PharmD, MBA, BCPS   +3 more
doaj   +1 more source

Risperidone-induced Premature Ventricular Complexes in Psychosis: A Case Report [PDF]

open access: yesIndian Journal of Private Psychiatry, 2023
Atypical antipsychotics are known to cause cardiovascular side effects, such as prolonging the QTc interval due to blockade of the potassium repolarization channels, and hence they predispose to ventricular arrhythmias, like premature ventricular ...
Javed A Siddiqui   +2 more
doaj   +1 more source

Pharmacological Interventions to Treat Antipsychotic-Induced Dyslipidemia in Schizophrenia Patients: A Systematic Review and Meta Analysis

open access: yesFrontiers in Psychiatry, 2021
Introduction: Antipsychotic-induced dyslipidemia represents a common adverse effect faced by patients with schizophrenia that increases risk for developing further metabolic complications and cardiovascular disease.
Pruntha Kanagasundaram   +21 more
doaj   +1 more source

Effect of Atypical Antipsychotic Medications on the Risk of Obstructive Sleep Apnea in Individuals With Schizophrenia [PDF]

open access: yesSleep Medicine Research, 2022
Background and Objective Weight gain and obesity could be side effects of taking atypical antipsychotic medications. They are major risk factors for obstructive sleep apnea.
Habibolah Khazaie   +5 more
doaj   +1 more source

Home - About - Disclaimer - Privacy